Treating Cancers Resistant to ALL Drugs a Priority for Researchers. See What Merck and Kintara Have Done

Merck and Kintara in the NEWS
Treating cancers that have no treatments should be a priority for researchers to create a treatment for them.  Patients who are afflicted with untreatable deadly diseases might not have a single drop of hope in survival  from these untreatable cancers. In yesterday's news, we fell on a treatment by Merck that demonstrated statistically significant and clinically meaningful improvement in patients with high-risk of locally advanced cervical cancer, which is a terrible life - threatening cancer.

We also have another  company dedicated to treating untreatable cancers, including the deadly brain Glioblastoma (GBM) and other . . .

This content is for paid subscribers.
Please click here to subscribe or here to log in.